Augustine Asset Management Inc Pfizer Inc Transaction History

Augustine Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $1.56 Million - $1.78 Million	-40,535 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $15,373 - $18,647	-446 Reduced 1.09%	40,535 $1.79 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $277,808 - $322,296	8,706 Added 26.97%	40,981 $1.45 Million
Q4 2017 Jan 22, 2018	BUY	$33.26 - $35.29 $444,054 - $471,156	13,351 Added 70.55%	32,275 $1.17 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $586,644 - $646,254	18,924	18,924 $675,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Augustine Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Augustine Asset Management Inc with notifications on news.